Recent evidence has demonstrated that natural compounds which increase the endogenous expression of BDNF and/or TrkB, as well as BDNF mimetic compounds that are small molecules passing the blood–brain barrier (BBB), look promising to treat brain diseases including mental and neurological disorders. The gene discussed is NTRK2; the disease is nervous system disorder.